Apollomics Completes Patient Enrollment for Phase 3 Trial of Leukemia Treatment
By Exec Edge Editorial Staff Apollomics Inc. (Nasdaq: APLM) said it completed patient enrollment in...
Editorial
Eterna Therapeutics Appoints Sanjeev Luther as President and CEO
By Healthcare Edge Editorial Staff Eterna Therapeutics Inc. (Nasdaq: ERNA) said it appointed Sanjeev Luther...
ProSomnus Treatment for Sleep Apnea Effective, Study Shows
By Healthcare Edge Editorial Staff ProSomnus, Inc. (NASDAQ: OSA), a pioneer in non-CPAP Obstructive Sleep...
reAlpha to Acquire United Software Group to Boost AI Capabilities
By Tech Edge Editorial Staff Real estate technology company reAlpha Tech Corp. (Nasdaq: AIRE) said...
Real Estate Trends & Challenges: ICR Partner Jason Chudoba Live from NYSE
PE Edge hosted a fireside chat from the floor of the New York Stock Exchange...
Creating Value in Electric Utility Industry: RS Technologies CEO George Kirby, Live from NYSE
IPO Edge hosted a fireside chat from the floor of the New York Stock Exchange...
AI in Practice – From Fintech to Aviation Panel at 3rd Palm Beach CorpGov Forum
By Tech Edge Editorial Staff Tech Edge and Exec Edge are please to provide...
Apollomics Presents Data from Phase 2 Clinical Trials of Lung Cancer Medication
By Thomas S. Green Apollomics Inc. (Nasdaq: APLM) said it saw strong results from two...
Duckhorn Portfolio 1Q Net Income at High End of Expectations
By Thomas S. Green The Duckhorn Portfolio, Inc. (NYSE: NAPA) said fiscal first quarter net...
Vince Holding 3Q Profit Climbs on Cost Savings Program
By Thomas S. Green Vince Holding Corp. (NYSE: VNCE) said third quarter gross profit was...
© Copyright 2025, ExecEdge